Gene · 84939
PWWP3A: PWWP domain containing 3A, DNA repair factor
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. PWWP3A: PWWP domain containing 3A, DNA repair factor. Genes, record 84939. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/84939
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q2TAK8 | PWWP domain-containing DNA repair factor 3A | 710 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents2
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants674
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | PWWP3A papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 35 | 2025 |
| ZIASC000550 | Lymphoma Disease Discovery and Definition | 29 | 2025 |
| ZIABC011070 | Hematopathology Diagnosis | 28 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 21 | 2025 |
| ZIEBC011241 | Hematopathology Fellowship | 17 | 2025 |
| ZICBC011079 | Molecular Diagnostics Core Laboratory | 8 | 2025 |
| U01CA195568 | The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study | 6 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 5 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 5 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 5 | 2025 |
1 to 10 of 674Source NIH's project files
See all 674 nih grantsPapers3,940
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Concurrent follicular lymphoma and follicular dendritic cell sarcoma: composite neoplasm or transdifferentiation? | J Hematop | 2026 | 42799816 | PubTator, text mining | PubMed |
| Large B-cell lymphoma with IRF4 rearrangement: clinicopathologic heterogeneity across the age spectrum. | J Hematop | 2026 | 42726346 | PubTator, text mining | PubMed |
| Case Report: Sinonasal plasmablastic lymphoma in a human immunodeficiency virus-negative elderly woman diagnosed by immunohistochemistry. | Front Med (Lausanne) | 2026 | 42718890 | PubTator, text mining | PubMed |
| Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements. | J Hematop | 2026 | 42704559 | PubTator, text mining | PubMed |
| Pediatric Mediastinal Gray Zone Lymphoma With Germline TET2 Heterozygous Variant. | Pediatr Blood Cancer | 2026 | 42657693 | PubTator, text mining | PubMed |
| Correlation Between Hysteroscopic Findings and Histopathological Evidence of Chronic Endometritis in Reproductive Age Women With Gynecological Disorders. | J Minim Invasive Gynecol | 2026 | 42617996 | PubTator, text mining | PubMed |
| Secondary Diffuse Large B-Cell Lymphoma After Sequential Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia: A Case Report. | Case Rep Hematol | 2026 | 42583136 | PubTator, text mining | PubMed |
| Gastric plasmacytoma with loss of Cd138 expression mimicking extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report. | Int J Surg Case Rep | 2026 | 42578155 | PubTator, text mining | PubMed |
| Diversified cell origin of Helicobacter pylori eradication-responsive gastric diffuse large B-cell lymphomas. | J Pathol | 2026 | 42554009 | PubTator, text mining | PubMed |
| Sporadic Burkitt Lymphoma Lacking MYC Protein Expression: A Rare Entity With Diagnostic Pitfalls and Dismal Prognosis. | Am J Surg Pathol | 2026 | 42533724 | PubTator, text mining | PubMed |
1 to 10 of 3,940
See all 3,940 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/84939
GET https://conductscience.org/api/genes/v1/84939/grants?page=2